Andaliman (Zanthoxylum acanthopodium DC.) fruit ethanolic extract exerts attenuative effect on hyperglycemia, sensory and motoric function's disorders in alloxan-induced diabetic mice
- PMID: 38370902
- PMCID: PMC10868678
- DOI: 10.5455/javar.2023.j716
Andaliman (Zanthoxylum acanthopodium DC.) fruit ethanolic extract exerts attenuative effect on hyperglycemia, sensory and motoric function's disorders in alloxan-induced diabetic mice
Abstract
Objective: Andaliman (Zanthoxylum acanthopodium) is a potent medicinal plant in Asia. This present study aimed to reveal the effectivity of Andaliman fruit extract in alleviating hyperglycemia, sensory and motoric balance disorders, histopathology of the cerebellum, and tissue oxidative stress in diabetic mice induced by alloxan.
Materials and methods: Diabetes induction was performed by intraperitoneally injecting alloxan monohydrate [200 mg/kg body weight (BW)]. Subsequently, the mice were treated daily with an ethanolic extract of Andaliman fruit (0, 150, 300, 450 mg/kg BW per oral) for 28 days, followed by measurements of blood glucose, paw sensitivity, motoric balance, histopathology of the cerebellum, and malondialdehyde (MDA) levels. Moreover, the phytochemical constituents of the extract were elucidated by liquid chromatography.
Results: Higher doses of Andaliman fruit extract could significantly attenuate the elevation of random and fasting blood glucose (p < 0.05) and improve paw sensitivity responses (p < 0.05) and motoric balances (p < 0.05) in diabetic mice. Moreover, Andaliman fruit extract could significantly attenuate the degeneration of cerebellar Purkinje cells (p < 0.05) and suppress MDA levels in the blood (p < 0.05) while blunting the MDA in the brain tissue (p < 0.05). Phytochemical screening revealed 39 compounds in the Andaliman extract belonging to the groups of alkaloids (26 compounds), flavonoids (12 compounds), and terpenoids (1 compound).
Conclusion: The ethanolic extract of Andaliman fruit is capable of ameliorating diabetic neuropathy, motor balance disorders, and Purkinje cell degeneration while also reducing oxidative stress in the peripheral system. Hence, Andaliman extract is a promising candidate for formulation as an herbal remedy against the detrimental outcomes of diabetes mellitus.
Keywords: Alkaloids; diabetes mellitus; diabetic neuropathy; herbal remedies; malondialdehyde.
Copyright: © Journal of Advanced Veterinary and Animal Research.
Conflict of interest statement
There was no conflict of interest to be declared.
Figures





Similar articles
-
Phytochemical Analysis by FTIR of Zanthoxylum Acanthopodium, DC Fruit Ethanol Extract, N-hexan, Ethyl Acetate and Water Fraction.Med Arch. 2023;77(3):183-188. doi: 10.5455/medarh.2023.77.183-188. Med Arch. 2023. PMID: 37700927 Free PMC article.
-
The effect of Andaliman (Zanthoxylum acanthopodium DC.) fruit extracted with ethanol on TNF-α and TRPA-1 levels in type II diabetes-induced mice.J Adv Vet Anim Res. 2024 Jun 6;11(2):284-290. doi: 10.5455/javar.2024.k774. eCollection 2024 Jun. J Adv Vet Anim Res. 2024. PMID: 39101085 Free PMC article.
-
Cardioprotective Effect of Hydroalcohol Extract of Andaliman (Zanthoxylum acanthopodium DC.) Fruits on Doxorubicin-Induced Rats.Pharmaceuticals (Basel). 2024 Mar 10;17(3):359. doi: 10.3390/ph17030359. Pharmaceuticals (Basel). 2024. PMID: 38543145 Free PMC article.
-
Andaliman (Zanthoxylum acanthopodium DC.) a herbal medicine from North Sumatera, Indonesia: Phytochemical and pharmacological review.Heliyon. 2023 May 12;9(5):e16159. doi: 10.1016/j.heliyon.2023.e16159. eCollection 2023 May. Heliyon. 2023. PMID: 37251868 Free PMC article. Review.
-
Bacterial cellulose impregnated with andaliman (Zanthoxylum acanthopodium) microencapsulation as diabetic wound dressing.Int J Biol Macromol. 2023 Dec 31;253(Pt 1):126572. doi: 10.1016/j.ijbiomac.2023.126572. Epub 2023 Aug 28. Int J Biol Macromol. 2023. PMID: 37648123 Review.
References
-
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Res Clin Pract. 2019;157:107843. https://dx.doi.org/10.1016/j.diabres.2019.107843. - PubMed
-
- Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, et al. Assessing cardiovascular risk in patients with diabetes: an update. Curr Cardiol Rev. 2020;16(4):266–74. https://dx.doi.org/10.2174/1573403x15666191111123622. - PMC - PubMed
-
- Farhan LO, Abed BA, Dawood A. Comparison study between adipsin levels in sera of Iraqi patients with diabetes and neuropathy. Baghdad Sci J. 2023;20(3):0726. https://dx.doi.org/10.21123/bsj.2022.7408.
-
- Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Prim Care. 2020;47(4):645–59. https://dx.doi.org/10.1016/j.pop.2020.08.004. - PubMed
-
- Hamed AE, Elwan N, Naguib M, Elwakil R, Esmat G, El Kassas M, et al. Diabetes association with liver diseases: an overview for clinicians. Endocr Metab Immune Disord Drug Targets. 2019;19(3):274–80. https://dx.doi.org/10.2174/1573399815666191024085838. - PubMed
LinkOut - more resources
Full Text Sources